Solventum Stock Earnings Reports

Solventum reported a strong start to fiscal 2026, with Q1 results ahead of plan and Street expectations. Organic sales grew ~2.1% (reported sales down ~3% due to divestiture and FX impacts), margins expanded driven by programmatic savings, improved mix and sales leverage, and adjusted EPS rose to $1.48 (about +11%). Key execution highlights: continued separation progress from 3M (50% of TSAs exited, ~75% of applications migrated, Asia ERP cutover completed; U.S./Canada ERP cutover planned for Q3), completion of >50% SKU rationalization (on track to finish by year-end), integration of Acera (contributed ~$28M in Q1, expected to be a meaningful growth contributor), and ongoing Transform for the Future cost-savings program targeted at $500M. Management reiterated full-year guidance for organic sales growth and free cash flow, raised confidence that FY EPS will be toward the high end of the $6.40–$6.60 range, and reiterated operating margin expansion of 50–100 bps for 2026 despite tariff headwinds (tariffs still modeled at $100–$120M). They flagged material sales phasing tied to the upcoming U.S. ERP cutover —management estimates >$100M of orders pulled into Q2 that will largely reverse in Q3— and began a $1B share buyback authorization (approx. $67M repurchased in Q1). Balance sheet: cash $561M, net debt ~$4.5B; first-quarter free cash flow ahead of expectations but seasonally lowest quarter. Management emphasized ongoing portfolio optimization (both divestitures and tuck-in M&A) and a pipeline of ~20 new product launches over the next two years to sustain organic growth and commercial momentum.